関: viomycin sulfate

WordNet

a basic polypeptide antibiotic (trade name Viocin) administered intramuscularly (along with other drugs) in the treatment of tuberculosis (同)Viocin

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2013/07/17 03:13:09」(JST)

wiki en

Viomycin is a member of the tuberactinomycin family,^[1]^[2]^[3] a group of nonribosomal peptide antibiotics exhibiting anti-tuberculosis properties. The tuberactinomycin family is an essential component in the drug cocktail currently used to fight infections of Mycobacterium tuberculosis. Viomycin was the first member of the tuberactinomycins to be isolated and identified^[4] and was used to treat TB until it was replaced by the less toxic, but structurally related compound, capreomycin. The tuberactinomycins target bacterial ribosomes, binding RNA and disrupting bacterial protein biosynthesis. It is produced by the actinomycete Streptomyces puniceus, that binds to RNA and inhibits prokaryotic protein synthesis and certain forms of RNA splicing.

Biosynthesis[edit]

The gene cluster for viomycin has been sequenced from Streptomyces sp. strain ATCC 11861,^[5] Streptomyces vinaceus^[6] and from Streptomyces lividans 1326.^[4] It consists of a central cyclic pentapeptide code assembled from nonribosomal peptide synthetase (NRPS). The NRPS contains 4 proteins: VioA, VioF, VioI, and VioG. These proteins condense and cyclize two molecules of L-2,3-diaminopropionate (L-Dap), two molecules of L-serine (L-Ser), and one molecule of (2S,3R)-capreomycidine (L-Cam). After cyclizing these, VioJ catalyzes the α,β-desaturation of this preliminary structure. It is proposed that the viomycin gene cluster includes 36.3 kb of contiguous DNA that encodes 20 open reading frames (ORFs)^[5] that are involved in the biosynthesis, regulation, and eventual activation viomycin. In addition to these ORFs, the structure contains the resistance gene vph. The following is a summary of the ORFs and their functions.

VioA: NRPS (A-PCP-C-A-PCP-C)
VioH: Type II thioesterase
VioO: NRPS (A-PCP)-β-lysine activation
VioB: 2,3-diaminopropionate synthase
VioI: NRPS (PCP-C)
VioP: Lysine 2,3-aminomutase
VioC: L-Arg hydroxylase

VIoJ: 2,3-diaminopropionyl α,β-desaturase
vph: Viomycin phosphotransferase
VioD: Capreomycidine synthase
VioK: Ornithine cyclodeaminase
VioQ: Capreomycidine hydroxylase
VioE: Permease
VioL: Carbamoyltransferase

VioR: Transcriptional regulator
VioF: NRPS (A-PCP-C)
VIoM: NRPS (C)-β-lysine transferase
VIoS: Viomycin-phosphate phosphatase
VioG: NRPS (A-PCP-C/)
VioN: MbtH homolog
VioT: Transcriptional regulator

Synthesis of the backbone[edit]

The following is the proposed biosynthesis of viomycin using NRPS-catalyzed peptide synthesis. There are five modules for cyclic pentapeptide biosynthesis, including one that lacks an adenylation domain (A). It is therefore proposed that one of the other A domains functions twice. Additionally, the NRPS subunits are not suspected to function in the order in which their genes are arranged, a characteristic of viomycin biosynthesis that is unlike typical NRPS-catalyzed peptide synthesis.^[4] The NRPS components function in the order of VioA→VioI→VioF→VioG to account for the incorporation of β-ureidoalanine (β-Uda). The first A domain of VioA creates an L-Dap-PCP intermediate on the first PCP domain. Meanwhile, the second A domain of VioA loads L-Ser onto the second PCP domain, as well as the PCP of VioI. The activation of β-Uda occurs via VioF, and VioG incorporates L-Cam.

Figure 1. Domain Organization of viomycin.

Post-modification[edit]

After α,β-desaturation via VioJ, three modifications to the preliminary cyclic structure occur. Hydroxylation of C-6 in the structure occurs by VioQ, N-acylation of α-amino group using β-lysine, VioO, and VioM, and carbamoylation of the β-amino group, producing β-ureidoalanine (β-Uda) by the carbamoyltransferase homologue VioL.

Figure 2. Post-modification of Viomycin.

References[edit]

^ B. W. Bycroft (1972). Chem. Commun.: 660.
^ Noda et al.; Take, T; Nagata, A; Wakamiya, T; Shiba, T (1972). "Chemical studies on tuberactinomycin. 3. The chemical structure of viomycin (tuberactinomycin B)". J. Antibiot. 25 (7): 427. PMID 4350196.
^ T. Kitagawa et al. (1972). "The total structure of viomycin by sequential analysis". Chem. Pharm. Bull. 20 (10): 2215. PMID 4346588.
^ ^a ^b ^c Barkei, J.; Kevany, B.; Felnagle, E.; Thomas, M. (2009). "Investigations into viomycin biosynthesis by using heterologous production in Streptomyces lividans.". ChemBioChem. 10 (2): 366. doi:10.1002/cbic.200800646. PMC 2765823. PMID 19105177.
^ ^a ^b Thomas, M.; Chan, Y.; Ozanick, S., (2003). "Deciphering tuberactinomycin biosynthesis: isolation, sequencing, and annotation of the viomycin biosynthetic gene cluster.". Antimicrob. Agents Chemother. 47 (9): 2823. doi:10.1128/AAC.47.9.2823-2830.2003. PMC 182626. PMID 12936980.
^ Yin, X.; O'Hare, T.; Gould, S.; Zabriskie, M., (2003). "Identification and cloning of genes encoding viomycin biosynthesis from Streptomyces vinaceus and evidence for involvement of a rare oxygenase.". Gene 312: 215. doi:10.1016/S0378-1119(03)00617-6. PMID 12909358.

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 思春期における多嚢胞性卵巣症候群の診断的評価 diagnostic evaluation of polycystic ovary syndrome in adolescents
2. 成人における胸痛の診断的アプローチ diagnostic approach to chest pain in adults
3. 乳頭浮腫の概要および鑑別診断 overview and differential diagnosis of papilledema
4. 成人における確定診断を得られていない低血圧やショックの評価および初期アプローチ evaluation of and initial approach to the adult patient with undifferentiated hypotension and shock
5. 胃炎および胃障害の分類と診断 classification and diagnosis of gastritis and gastropathy

English Journal

Streptomyces sundarbansensis sp. nov., an actinomycete that produces 2-allyloxyphenol.

Arumugam M, Mitra A, Pramanik A, Saha M, Gachhui R, Mukherjee J.SourceSchool of Environmental Studies, Jadavpur University, Kolkata 700 032, India.
International journal of systematic and evolutionary microbiology.Int J Syst Evol Microbiol.2011 Nov;61(Pt 11):2664-9. Epub 2010 Dec 10.
A novel actinomycete producing 2-allyloxyphenol, designated strain MS1/7(T), was isolated from sediments of the Sundarbans mangrove forest, India. Growth on International Streptomyces Project (ISP) media 2, 3, 4, 5 and 7 produced olive green to grey aerial hyphae that carried smooth-surfaced spores
PMID 21148669

Molecular basis for the selectivity of antituberculosis compounds capreomycin and viomycin.

Akbergenov R, Shcherbakov D, Matt T, Duscha S, Meyer M, Wilson DN, Böttger EC.SourceInstitut für Medizinische Mikrobiologie, Universität Zürich, Gloriastrasse 30/32, 8006 Zürich, Switzerland.
Antimicrobial agents and chemotherapy.Antimicrob Agents Chemother.2011 Oct;55(10):4712-7. Epub 2011 Jul 18.
Capreomycin and the structurally similar compound viomycin are cyclic peptide antibiotics which are particularly active against Mycobacterium tuberculosis, including multidrug resistant strains. Both antibiotics bind across the ribosomal interface involving 23S rRNA helix 69 (H69) and 16S rRNA helix
PMID 21768509

Japanese Journal

Identification and cloning of genes encoding viomycin biosynthesis from Streptomyces vinaceus and evidence for involvement of a rare oxygenase

Gene 312, 215-224, 2003
NAID 80016136288

In Vitro Microbiological Characterization of Novel Cyclic Homopentapeptides, CP-101,680 and CP-163,234, for Animal Health Use.

The Journal of Antibiotics 52(11), 1007-1016, 1999
NAID 130003503518

Molecular analysis of kanamycin and viomycin resistance in Mycobacterium smegmatis by use of the conjugation system

J Bacteriol 179, 4795, 1997
NAID 80009763226

Related Pictures

★リンクテーブル★

リンク元	「バイオマイシン」「ビオマイシン」「VM」
拡張検索	「enviomycin sulfate」「viomycin sulfate」

「バイオマイシン」

Viomycin
Systematic (IUPAC) name
	(S)-3,6-Diamino-N-((3S,9S,12S,15S,Z)-((2R,4S)-6-amino-4-hydroxy-1,2,3,4-tetrahydropyridin-2-yl)-9,12-bis(hydroxymethyl)2,5,8,11,14-pentaoxo-6-(ureidomethylene)-1,4,7,10,13-pentaazacyclohexadecan-15-yl)hexanamide
Clinical data
Pregnancy cat.	?
Legal status	?
Routes	Intramuscular injection
Identifiers
CAS number	32988-50-4
ATC code	None
PubChem	CID 3037981
ChemSpider	2301596
UNII	YVU35998K5
ChEBI	CHEBI:15782
ChEMBL	CHEMBL1201221
Chemical data
Formula	C25H43N13O10
Mol. mass	685.691 g/mol
	SMILES C1[C@@H](NC(=N[C@H]1O)N)[C@H]2C(=O)NC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N/C(=C\NC(=O)N)/C(=O)N2)CO)CO)NC(=O)C[C@H](CCCN)N;
	InChI InChI=1S/C25H43N13O10/c26-3-1-2-10(27)4-16(41)32-12-6-30-23(47)18(11-5-17(42)37-24(28)36-11)38-20(44)13(7-31-25(29)48)33-21(45)14(8-39)35-22(46)15(9-40)34-19(12)43/h7,10-12,14-15,17-18,39-40,42H,1-6,8-9,26-27H2,(H,30,47)(H,32,41)(H,33,45)(H,34,43)(H,35,46)(H,38,44)(H3,28,36,37)(H3,29,31,48)/b13-7-/t10-,11+,12-,14-,15-,17-,18-/m0/s1 ; Key:GXFAIFRPOKBQRV-GHXCTMGLSA-N ;
(what is this?) (verify);